In many areas, laser medicine has established new methods and procedures. The biolitec group has been providing a crucial impetus for nearly twenty years: innovations are translated into breakthroughs that have simplified therapy for doctors and patients.
Therefore we conduct intensive research on how laser and photo-dynamic substances can be used to make further improvements in traditional processes and methods. These innovations clearly symbolize progress in medicine.
Moreover, our presence in the global core markets ensures positive business development thus forming the basis of our further expansion.
This is why in many countries, biolitec is today's market leader. The company-owned production plants in Europe, the USA and Asia provide on-site market proximity and the required flexibility. We offer special solutions, an an individual service for our customers.
In doing so, we constantly pay attention to the high quality of our products. Through interchange with users, biolitec biomedical technology GmbH constantly optimizes its processes in order to realise innovations in a better and faster way.
Wholly specializing in the development of new optical fibers, connectors, and medical laser systems is CeramOptec GmbH, a hundred percent subsidiary of biolitec group. With over 25 years of experience, CeramOptec has been a driving force in the field of optical fibers and develops custom products for numerous applications of biolitec biomedical technology GmbH, but also for highly diverse industries, such as environmental analytics, biochemistry, industrial laser delivery as well as aerospace and avionics. Furthermore, the company takes active part in a number of publicly funded research projects within national, European and international frameworks.
More information on CeramOptec and its products can be found on the company’s website at www.ceramoptec.com.
